WO2000025751A3 - Composition d'amoxycilline et de clavulanate amelioree - Google Patents

Composition d'amoxycilline et de clavulanate amelioree Download PDF

Info

Publication number
WO2000025751A3
WO2000025751A3 PCT/US1999/025058 US9925058W WO0025751A3 WO 2000025751 A3 WO2000025751 A3 WO 2000025751A3 US 9925058 W US9925058 W US 9925058W WO 0025751 A3 WO0025751 A3 WO 0025751A3
Authority
WO
WIPO (PCT)
Prior art keywords
amoxycillin
improved
clavulanate composition
clavulanate
composition
Prior art date
Application number
PCT/US1999/025058
Other languages
English (en)
Other versions
WO2000025751A2 (fr
Inventor
Peter Moir
Siobhan Greene
Original Assignee
Fuisz International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE980903A external-priority patent/IE980903A1/en
Priority claimed from US09/304,786 external-priority patent/US6177421B1/en
Application filed by Fuisz International Ltd filed Critical Fuisz International Ltd
Priority to AU12325/00A priority Critical patent/AU1232500A/en
Publication of WO2000025751A2 publication Critical patent/WO2000025751A2/fr
Publication of WO2000025751A3 publication Critical patent/WO2000025751A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'invention concerne une combinaison stable au stockage d'un antibiotique et d'un inhibiteur de bêta-lactame, cette combinaison étant transformée en comprimés par compression.
PCT/US1999/025058 1998-10-30 1999-10-26 Composition d'amoxycilline et de clavulanate amelioree WO2000025751A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU12325/00A AU1232500A (en) 1998-10-30 1999-10-26 Improved amoxycillin and clavulanate composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE980903A IE980903A1 (en) 1998-10-30 1998-10-30 Improved amoxycillin and clavulanate composition
IE980903 1998-10-30
US09/304,786 1999-05-04
US09/304,786 US6177421B1 (en) 1999-05-04 1999-05-04 Amoxicillin and clavulanate composition

Publications (2)

Publication Number Publication Date
WO2000025751A2 WO2000025751A2 (fr) 2000-05-11
WO2000025751A3 true WO2000025751A3 (fr) 2000-08-10

Family

ID=26320220

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/025058 WO2000025751A2 (fr) 1998-10-30 1999-10-26 Composition d'amoxycilline et de clavulanate amelioree

Country Status (2)

Country Link
AU (1) AU1232500A (fr)
WO (1) WO2000025751A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0312728A (pt) * 2002-07-16 2005-04-26 Ranbaxy Lab Ltd Formulação em tablete dispersìvel e processo para sua preparação

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2005538A (en) * 1977-10-11 1979-04-25 Beecham Group Ltd Compositions containing amoxycillin trihydrate and potassium clavulanate
WO1992008463A1 (fr) * 1990-11-15 1992-05-29 Rhone-Poulenc Rorer S.A. Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
WO1992019227A2 (fr) * 1991-05-08 1992-11-12 Laboratorios Beecham Sa Preparations pharmaceutiques
WO1997033564A1 (fr) * 1996-03-13 1997-09-18 Biochemie Gesellschaft Mbh Agglomerats renfermant des composes de betalactamines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2005538A (en) * 1977-10-11 1979-04-25 Beecham Group Ltd Compositions containing amoxycillin trihydrate and potassium clavulanate
WO1992008463A1 (fr) * 1990-11-15 1992-05-29 Rhone-Poulenc Rorer S.A. Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
WO1992019227A2 (fr) * 1991-05-08 1992-11-12 Laboratorios Beecham Sa Preparations pharmaceutiques
WO1997033564A1 (fr) * 1996-03-13 1997-09-18 Biochemie Gesellschaft Mbh Agglomerats renfermant des composes de betalactamines

Also Published As

Publication number Publication date
WO2000025751A2 (fr) 2000-05-11
AU1232500A (en) 2000-05-22

Similar Documents

Publication Publication Date Title
EP1283034A3 (fr) Agglomérés d'antibiotiques du type beta-lactame
AU3109099A (en) Allosteric inhibitors and activators of pyruvate kinase
AU6955394A (en) Vascularization inhibitor and novel compound
AU3967195A (en) Amidino and guanidino substituted inhibitors of trypsin-like enzymes
AU5208193A (en) Guanidinyl-substituted heterocyclic thrombin inhibitors
AU2001283186A1 (en) Simultaneous formation of charge storage and bitline to worldline isolation
AU7145294A (en) Heterocyclic thrombin inhibitors
EP1193270A3 (fr) Pyrrolobenzodiazépines
AU5748194A (en) Mannitol derivatives and their use as inhibitors of aspartyl protease
IL145580A0 (en) A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
AU1515295A (en) Inhibitors of urokinase plasminogen activator
AU5814096A (en) Composition comprising amoxycillin and clavulanic acid
AU8917098A (en) Azetidinone derivatives as beta-lactamase inhibitors
HK1043042A1 (zh) 含有阿莫西林和棒酸鹽的藥用加工製劑
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
AU6183794A (en) Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors
AU5863894A (en) Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
AU2251892A (en) Inhibitors of picornavirus proteases
AU6703894A (en) Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
AU6183494A (en) Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors
AU7478694A (en) 3-aryl or heteroaryl-7-heteroaralkylamido cephalosporin compounds, compositions and methods of use
AU3162893A (en) Use of amphotericin b derivatives as protease inhibitors
AU5812294A (en) Combination of angiotensin converting enzyme inhibitors and aii antagonists
AU4552597A (en) Pharmaceutical composition containing lornoxicam and a disodic salt of edta

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 12325

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase